miRNA screening through nipple aspiration sampling

Updates in prostate and bladder cancer therapy

Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists

Editor's Choice for July 2016

Towards deciphering the functional genetics and neo-antigenic landscape in melanoma

Prof Michael Seckl: Why attend Future Horizons in Lung Cancer?

DNA repair and mutations as targets for personalised therapy

Obesity promotes pancreatic cancer progression and resistance

Connections in cancer-host immune signalling

ERß expression predicts breast cancer risk in hyperplasia

Advances in early detection

Regulation of T cells in tissues and tumours